Home/XORTX Therapeutics/Allen Davidoff

AD

Allen Davidoff

Chief Executive Officer & Director

XORTX Therapeutics

Therapeutic Areas

Nephrology Metabolic Disorders

XORTX Therapeutics Pipeline

Drug	Indication	Phase
Oxypurinol (XRX-OXY)	Autosomal Dominant Polycystic Kidney Disease (ADPKD)	Phase 3
XRX-008	Renal Disease associated with Type 2 Diabetes	Preclinical

Leadership Team at XORTX Therapeutics

Michael Hartmann

Vice President, Clinical Development

View full XORTX Therapeutics profile